 | • レポートコード：QY2108PAL8926 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、153ページ • 納品方法：Eメール（納期：1日） • 産業分類：医薬品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の当調査資料ではグローバルにおけるラニチジン（ザンタック）の市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、ラニチジン（ザンタック）の種類別市場規模（ラニチジンカプセル、ラニチジン経口錠剤、ラニチジン注射液、ラニチジン経口シロップ）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。 ・調査の概要 ・調査のサマリー ・世界のラニチジン（ザンタック）市場動向 ・グローバル主要プレイヤーの競争状況・市場シェア ・世界におけるラニチジン（ザンタック）の種類別市場規模（2016年-2027年）：ラニチジンカプセル、ラニチジン経口錠剤、ラニチジン注射液、ラニチジン経口シロップ ・世界におけるラニチジン（ザンタック）の用途別市場規模（2016年-2027年）：病院薬局、小売薬局、オンライン薬局 ・ラニチジン（ザンタック）の中国市場分析 - ラニチジン（ザンタック）の中国市場規模（2016年-2027年） - 中国におけるラニチジン（ザンタック）の主要プレイヤー別市場シェア - 中国におけるラニチジン（ザンタック）の種類別市場規模：ラニチジンカプセル、ラニチジン経口錠剤、ラニチジン注射液、ラニチジン経口シロップ - 中国におけるラニチジン（ザンタック）の用途別市場規模：病院薬局、小売薬局、オンライン薬局 ・ラニチジン（ザンタック）の北米市場（2016年-2027年） ・ラニチジン（ザンタック）のヨーロッパ市場（2016年-2027年） ・ラニチジン（ザンタック）のアジア太平洋市場（2016年-2027年） ・ラニチジン（ザンタック）の中南米市場（2016年-2027年） ・ラニチジン（ザンタック）の中東・アフリカ市場（2016年-2027年） ・主要プレイヤーの情報：Sanofi-Aventis、GlaxoSmithKline、Hi-Tech Pharmacal Co.、Sun Pharma、Mylan Pharmaceuticals Inc. (and Mylan Laboratories)、Dr. Reddy’s Laboratories Inc.、Sandoz Inc. (part of Novartis AG)、Strides (and Strides Arcolab international)、Geri-Care Pharmaceuticals、PAI Holdings, LLC、Teva Pharmaceuticals、Granules Pharmaceuticals Inc.、Glenmark Pharmaceuticals (and Glenmark Generics)、Apotex Inc. (and Apotex Corporation)、Hikma Pharmaceuticals (West-ward Pharmaceuticals) ・市場機会・課題・リスク要因分析 ・バリューチェーン・販売チャネル分析 ・... |
Market Analysis and Insights: Global and China Ranitidine (Zantac) Market
This report focuses on global and China Ranitidine (Zantac) market.
In 2020, the global Ranitidine (Zantac) market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In China the Ranitidine (Zantac) market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Ranitidine (Zantac) Scope and Market Size
Ranitidine (Zantac) market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Ranitidine (Zantac) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Ranitidine (Zantac) market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.
Segment by Type
Ranitidine Capsule
Ranitidine Oral Tablet
Ranitidine Injectable Solution
Ranitidine Oral Syrup
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Sanofi-Aventis
GlaxoSmithKline
Hi-Tech Pharmacal Co.
Sun Pharma
Mylan Pharmaceuticals Inc. (and Mylan Laboratories)
Dr. Reddy’s Laboratories Inc.
Sandoz Inc. (part of Novartis AG)
Strides (and Strides Arcolab international)
Geri-Care Pharmaceuticals
PAI Holdings, LLC
Teva Pharmaceuticals
Granules Pharmaceuticals Inc.
Glenmark Pharmaceuticals (and Glenmark Generics)
Apotex Inc. (and Apotex Corporation)
Hikma Pharmaceuticals (West-ward Pharmaceuticals)
1 Study Coverage
1.1 Ranitidine (Zantac) Product Introduction
1.2 Market by Type
1.2.1 Global Ranitidine (Zantac) Market Size Growth Rate by Type
1.2.2 Ranitidine Capsule
1.2.3 Ranitidine Oral Tablet
1.2.4 Ranitidine Injectable Solution
1.2.5 Ranitidine Oral Syrup
1.3 Market by Application
1.3.1 Global Ranitidine (Zantac) Market Size Growth Rate by Application
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Ranitidine (Zantac) Market Size, Estimates and Forecasts
2.1.1 Global Ranitidine (Zantac) Revenue 2016-2027
2.1.2 Global Ranitidine (Zantac) Sales 2016-2027
2.2 Global Ranitidine (Zantac), Market Size by Region: 2016 VS 2021 VS 2027
2.3 Ranitidine (Zantac) Historical Market Size by Region (2016-2021)
2.3.1 Global Ranitidine (Zantac) Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Ranitidine (Zantac) Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Ranitidine (Zantac) Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Ranitidine (Zantac) Sales Forecast by Region (2022-2027)
2.4.2 Global Ranitidine (Zantac) Revenue Forecast by Region (2022-2027)
3 Global Ranitidine (Zantac) Competitor Landscape by Players
3.1 Global Top Ranitidine (Zantac) Manufacturers by Sales
3.1.1 Global Ranitidine (Zantac) Sales by Manufacturer (2016-2021)
3.1.2 Global Ranitidine (Zantac) Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Ranitidine (Zantac) Manufacturers by Revenue
3.2.1 Key Ranitidine (Zantac) Manufacturers Covered: Ranking by Revenue
3.2.2 Global Ranitidine (Zantac) Revenue by Manufacturers (2016-2021)
3.2.3 Global Ranitidine (Zantac) Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Ranitidine (Zantac) Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Ranitidine (Zantac) Revenue in 2020
3.2.6 Global Ranitidine (Zantac) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Ranitidine (Zantac) Price by Manufacturers
3.4 Global Ranitidine (Zantac) Manufacturing Base Distribution, Product Types
3.4.1 Ranitidine (Zantac) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Ranitidine (Zantac) Product Type
3.4.3 Date of International Manufacturers Enter into Ranitidine (Zantac) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Ranitidine (Zantac) Market Size by Type (2016-2021)
4.1.1 Global Ranitidine (Zantac) Sales by Type (2016-2021)
4.1.2 Global Ranitidine (Zantac) Revenue by Type (2016-2021)
4.1.3 Ranitidine (Zantac) Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Ranitidine (Zantac) Market Size Forecast by Type (2022-2027)
4.2.1 Global Ranitidine (Zantac) Sales Forecast by Type (2022-2027)
4.2.2 Global Ranitidine (Zantac) Revenue Forecast by Type (2022-2027)
4.2.3 Ranitidine (Zantac) Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Ranitidine (Zantac) Market Size by Application (2016-2021)
5.1.1 Global Ranitidine (Zantac) Sales by Application (2016-2021)
5.1.2 Global Ranitidine (Zantac) Revenue by Application (2016-2021)
5.1.3 Ranitidine (Zantac) Price by Application (2016-2021)
5.2 Ranitidine (Zantac) Market Size Forecast by Application (2022-2027)
5.2.1 Global Ranitidine (Zantac) Sales Forecast by Application (2022-2027)
5.2.2 Global Ranitidine (Zantac) Revenue Forecast by Application (2022-2027)
5.2.3 Global Ranitidine (Zantac) Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Ranitidine (Zantac) Market Size YoY Growth 2016-2027
6.1.1 China Ranitidine (Zantac) Sales YoY Growth 2016-2027
6.1.2 China Ranitidine (Zantac) Revenue YoY Growth 2016-2027
6.1.3 China Ranitidine (Zantac) Market Share in Global Market 2016-2027
6.2 China Ranitidine (Zantac) Market Size by Players (International and Local Players)
6.2.1 China Top Ranitidine (Zantac) Players by Sales (2016-2021)
6.2.2 China Top Ranitidine (Zantac) Players by Revenue (2016-2021)
6.3 China Ranitidine (Zantac) Historic Market Review by Type (2016-2021)
6.3.1 China Ranitidine (Zantac) Sales Market Share by Type (2016-2021)
6.3.2 China Ranitidine (Zantac) Revenue Market Share by Type (2016-2021)
6.3.3 China Ranitidine (Zantac) Price by Type (2016-2021)
6.4 China Ranitidine (Zantac) Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Ranitidine (Zantac) Sales Forecast by Type (2022-2027)
6.4.2 China Ranitidine (Zantac) Revenue Forecast by Type (2022-2027)
6.4.3 China Ranitidine (Zantac) Price Forecast by Type (2022-2027)
6.5 China Ranitidine (Zantac) Historic Market Review by Application (2016-2021)
6.5.1 China Ranitidine (Zantac) Sales Market Share by Application (2016-2021)
6.5.2 China Ranitidine (Zantac) Revenue Market Share by Application (2016-2021)
6.5.3 China Ranitidine (Zantac) Price by Application (2016-2021)
6.6 China Ranitidine (Zantac) Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Ranitidine (Zantac) Sales Forecast by Application (2022-2027)
6.6.2 China Ranitidine (Zantac) Revenue Forecast by Application (2022-2027)
6.6.3 China Ranitidine (Zantac) Price Forecast by Application (2022-2027)
7 North America
7.1 North America Ranitidine (Zantac) Market Size YoY Growth 2016-2027
7.2 North America Ranitidine (Zantac) Market Facts & Figures by Country
7.2.1 North America Ranitidine (Zantac) Sales by Country (2016-2021)
7.2.2 North America Ranitidine (Zantac) Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Ranitidine (Zantac) Market Size YoY Growth 2016-2027
8.2 Asia Pacific Ranitidine (Zantac) Market Facts & Figures by Region
8.2.1 Asia Pacific Ranitidine (Zantac) Sales by Region (2016-2021)
8.2.2 Asia Pacific Ranitidine (Zantac) Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Ranitidine (Zantac) Market Size YoY Growth 2016-2027
9.2 Europe Ranitidine (Zantac) Market Facts & Figures by Country
9.2.1 Europe Ranitidine (Zantac) Sales by Country (2016-2021)
9.2.2 Europe Ranitidine (Zantac) Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Ranitidine (Zantac) Market Size YoY Growth 2016-2027
10.2 Latin America Ranitidine (Zantac) Market Facts & Figures by Country
10.2.1 Latin America Ranitidine (Zantac) Sales by Country (2016-2021)
10.2.2 Latin America Ranitidine (Zantac) Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Ranitidine (Zantac) Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Ranitidine (Zantac) Market Facts & Figures by Country
11.2.1 Middle East and Africa Ranitidine (Zantac) Sales by Country (2016-2021)
11.2.2 Middle East and Africa Ranitidine (Zantac) Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Sanofi-Aventis
12.1.1 Sanofi-Aventis Corporation Information
12.1.2 Sanofi-Aventis Description and Business Overview
12.1.3 Sanofi-Aventis Ranitidine (Zantac) Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Sanofi-Aventis Ranitidine (Zantac) Products Offered
12.1.5 Sanofi-Aventis Recent Development
12.2 GlaxoSmithKline
12.2.1 GlaxoSmithKline Corporation Information
12.2.2 GlaxoSmithKline Description and Business Overview
12.2.3 GlaxoSmithKline Ranitidine (Zantac) Sales, Revenue and Gross Margin (2016-2021)
12.2.4 GlaxoSmithKline Ranitidine (Zantac) Products Offered
12.2.5 GlaxoSmithKline Recent Development
12.3 Hi-Tech Pharmacal Co.
12.3.1 Hi-Tech Pharmacal Co. Corporation Information
12.3.2 Hi-Tech Pharmacal Co. Description and Business Overview
12.3.3 Hi-Tech Pharmacal Co. Ranitidine (Zantac) Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Hi-Tech Pharmacal Co. Ranitidine (Zantac) Products Offered
12.3.5 Hi-Tech Pharmacal Co. Recent Development
12.4 Sun Pharma
12.4.1 Sun Pharma Corporation Information
12.4.2 Sun Pharma Description and Business Overview
12.4.3 Sun Pharma Ranitidine (Zantac) Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Sun Pharma Ranitidine (Zantac) Products Offered
12.4.5 Sun Pharma Recent Development
12.5 Mylan Pharmaceuticals Inc. (and Mylan Laboratories)
12.5.1 Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Corporation Information
12.5.2 Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Description and Business Overview
12.5.3 Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Ranitidine (Zantac) Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Ranitidine (Zantac) Products Offered
12.5.5 Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Recent Development
12.6 Dr. Reddy’s Laboratories Inc.
12.6.1 Dr. Reddy’s Laboratories Inc. Corporation Information
12.6.2 Dr. Reddy’s Laboratories Inc. Description and Business Overview
12.6.3 Dr. Reddy’s Laboratories Inc. Ranitidine (Zantac) Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Dr. Reddy’s Laboratories Inc. Ranitidine (Zantac) Products Offered
12.6.5 Dr. Reddy’s Laboratories Inc. Recent Development
12.7 Sandoz Inc. (part of Novartis AG)
12.7.1 Sandoz Inc. (part of Novartis AG) Corporation Information
12.7.2 Sandoz Inc. (part of Novartis AG) Description and Business Overview
12.7.3 Sandoz Inc. (part of Novartis AG) Ranitidine (Zantac) Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Sandoz Inc. (part of Novartis AG) Ranitidine (Zantac) Products Offered
12.7.5 Sandoz Inc. (part of Novartis AG) Recent Development
12.8 Strides (and Strides Arcolab international)
12.8.1 Strides (and Strides Arcolab international) Corporation Information
12.8.2 Strides (and Strides Arcolab international) Description and Business Overview
12.8.3 Strides (and Strides Arcolab international) Ranitidine (Zantac) Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Strides (and Strides Arcolab international) Ranitidine (Zantac) Products Offered
12.8.5 Strides (and Strides Arcolab international) Recent Development
12.9 Geri-Care Pharmaceuticals
12.9.1 Geri-Care Pharmaceuticals Corporation Information
12.9.2 Geri-Care Pharmaceuticals Description and Business Overview
12.9.3 Geri-Care Pharmaceuticals Ranitidine (Zantac) Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Geri-Care Pharmaceuticals Ranitidine (Zantac) Products Offered
12.9.5 Geri-Care Pharmaceuticals Recent Development
12.10 PAI Holdings, LLC
12.10.1 PAI Holdings, LLC Corporation Information
12.10.2 PAI Holdings, LLC Description and Business Overview
12.10.3 PAI Holdings, LLC Ranitidine (Zantac) Sales, Revenue and Gross Margin (2016-2021)
12.10.4 PAI Holdings, LLC Ranitidine (Zantac) Products Offered
12.10.5 PAI Holdings, LLC Recent Development
12.11 Sanofi-Aventis
12.11.1 Sanofi-Aventis Corporation Information
12.11.2 Sanofi-Aventis Description and Business Overview
12.11.3 Sanofi-Aventis Ranitidine (Zantac) Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Sanofi-Aventis Ranitidine (Zantac) Products Offered
12.11.5 Sanofi-Aventis Recent Development
12.12 Granules Pharmaceuticals Inc.
12.12.1 Granules Pharmaceuticals Inc. Corporation Information
12.12.2 Granules Pharmaceuticals Inc. Description and Business Overview
12.12.3 Granules Pharmaceuticals Inc. Ranitidine (Zantac) Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Granules Pharmaceuticals Inc. Products Offered
12.12.5 Granules Pharmaceuticals Inc. Recent Development
12.13 Glenmark Pharmaceuticals (and Glenmark Generics)
12.13.1 Glenmark Pharmaceuticals (and Glenmark Generics) Corporation Information
12.13.2 Glenmark Pharmaceuticals (and Glenmark Generics) Description and Business Overview
12.13.3 Glenmark Pharmaceuticals (and Glenmark Generics) Ranitidine (Zantac) Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Glenmark Pharmaceuticals (and Glenmark Generics) Products Offered
12.13.5 Glenmark Pharmaceuticals (and Glenmark Generics) Recent Development
12.14 Apotex Inc. (and Apotex Corporation)
12.14.1 Apotex Inc. (and Apotex Corporation) Corporation Information
12.14.2 Apotex Inc. (and Apotex Corporation) Description and Business Overview
12.14.3 Apotex Inc. (and Apotex Corporation) Ranitidine (Zantac) Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Apotex Inc. (and Apotex Corporation) Products Offered
12.14.5 Apotex Inc. (and Apotex Corporation) Recent Development
12.15 Hikma Pharmaceuticals (West-ward Pharmaceuticals)
12.15.1 Hikma Pharmaceuticals (West-ward Pharmaceuticals) Corporation Information
12.15.2 Hikma Pharmaceuticals (West-ward Pharmaceuticals) Description and Business Overview
12.15.3 Hikma Pharmaceuticals (West-ward Pharmaceuticals) Ranitidine (Zantac) Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Hikma Pharmaceuticals (West-ward Pharmaceuticals) Products Offered
12.15.5 Hikma Pharmaceuticals (West-ward Pharmaceuticals) Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Ranitidine (Zantac) Industry Trends
13.2 Ranitidine (Zantac) Market Drivers
13.3 Ranitidine (Zantac) Market Challenges
13.4 Ranitidine (Zantac) Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Ranitidine (Zantac) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Ranitidine (Zantac) Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Ranitidine Capsule
Table 3. Major Manufacturers of Ranitidine Oral Tablet
Table 4. Major Manufacturers of Ranitidine Injectable Solution
Table 5. Major Manufacturers of Ranitidine Oral Syrup
Table 6. Global Ranitidine (Zantac) Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 7. Global Ranitidine (Zantac) Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 8. Global Ranitidine (Zantac) Sales by Regions (2016-2021) & (K Units)
Table 9. Global Ranitidine (Zantac) Sales Market Share by Regions (2016-2021)
Table 10. Global Ranitidine (Zantac) Revenue by Regions (2016-2021) & (US$ Million)
Table 11. Global Ranitidine (Zantac) Sales Forecast by Region (2022-2027) & (K Units)
Table 12. Global Ranitidine (Zantac) Sales Market Share Forecast by Region (2022-2027)
Table 13. Global Ranitidine (Zantac) Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 14. Global Ranitidine (Zantac) Revenue Market Share Forecast by Region (2022-2027)
Table 15. Global Ranitidine (Zantac) Sales by Manufacturers (2016-2021) (K Units)
Table 16. Global Ranitidine (Zantac) Sales Share by Manufacturers (2016-2021)
Table 17. Ranking of Global Top Ranitidine (Zantac) Manufacturers by Revenue (US$ Million) in 2020
Table 18. Ranitidine (Zantac) Revenue by Manufacturers (2016-2021) (US$ Million)
Table 19. Ranitidine (Zantac) Revenue Share by Manufacturers (2016-2021)
Table 20. Global Ranitidine (Zantac) Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 21. Global Ranitidine (Zantac) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ranitidine (Zantac) as of 2020)
Table 22. Key Manufacturers Ranitidine (Zantac) Price (2016-2021) (US$/Unit)
Table 23. Ranitidine (Zantac) Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Ranitidine (Zantac) Product Type
Table 25. Date of International Manufacturers Enter into Ranitidine (Zantac) Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Ranitidine (Zantac) Sales by Type (2016-2021) (K Units)
Table 28. Global Ranitidine (Zantac) Sales Share by Type (2016-2021)
Table 29. Global Ranitidine (Zantac) Revenue by Type (2016-2021) (US$ Million)
Table 30. Global Ranitidine (Zantac) Revenue Share by Type (2016-2021)
Table 31. Ranitidine (Zantac) Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
Table 32. Global Ranitidine (Zantac) Sales Forecast by Type (2022-2027) & (K Units)
Table 33. Global Ranitidine (Zantac) Sales Market Share Forecast by Type (2022-2027)
Table 34. Global Ranitidine (Zantac) Revenue Forecast V (2022-2027) & (US$ Million)
Table 35. Global Ranitidine (Zantac) Revenue Market Share Forecast by Type (2022-2027)
Table 36. Global Ranitidine (Zantac) Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
Table 37. Global Ranitidine (Zantac) Sales by Application (2016-2021) (K Units)
Table 38. Global Ranitidine (Zantac) Sales Share by Application (2016-2021)
Table 39. Global Ranitidine (Zantac) Revenue by Application (2016-2021) (US$ Million)
Table 40. Global Ranitidine (Zantac) Revenue Share by Application (2016-2021)
Table 41. Ranitidine (Zantac) Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit)
Table 42. Global Ranitidine (Zantac) Sales Forecast by Application (2022-2027) & (K Units)
Table 43. Global Ranitidine (Zantac) Sales Market Share Forecast by Application (2022-2027)
Table 44. Global Ranitidine (Zantac) Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 45. Global Ranitidine (Zantac) Revenue Market Share Forecast by Application (2022-2027)
Table 46. Global Ranitidine (Zantac) Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit)
Table 47. China Ranitidine (Zantac) Sales (K Units) of Key Companies (2016-2021)
Table 48. China Ranitidine (Zantac) Sales Share by Company (2016-2021)
Table 49. China Ranitidine (Zantac) Revenue (US$ Million) by Company (2016-2021)
Table 50. China Ranitidine (Zantac) Revenue Share by Company (2016-2021)
Table 51. China Ranitidine (Zantac) Sales (K Units) by Type (2016-2021)
Table 52. China Ranitidine (Zantac) Sales Share by Type (2016-2021)
Table 53. China Ranitidine (Zantac) Revenue (US$ Million) Market Share by Type (2016-2021)
Table 54. China Ranitidine (Zantac) Price (US$/Unit) by Type (2016-2021)
Table 55. China Ranitidine (Zantac) Sales (K Units) by Type (2022-2027)
Table 56. China Ranitidine (Zantac) Sales Share by Type (2022-2027)
Table 57. China Ranitidine (Zantac) Revenue (US$ Million) Market Share by Type (2022-2027)
Table 58. China Ranitidine (Zantac) Revenue Share by Type (2022-2027)
Table 59. China Ranitidine (Zantac) Price (US$/Unit) by Type (2022-2027)
Table 60. China Ranitidine (Zantac) Sales (K Units) by Application (2016-2021)
Table 61. China Ranitidine (Zantac) Sales Share by Application (2016-2021)
Table 62. China Ranitidine (Zantac) Revenue (US$ Million) Market Share by Application (2016-2021)
Table 63. China Ranitidine (Zantac) Price (US$/Unit) by Application (2016-2021)
Table 64. China Ranitidine (Zantac) Sales (K Units) by Application (2022-2027)
Table 65. China Ranitidine (Zantac) Sales Share by Application (2022-2027)
Table 66. China Ranitidine (Zantac) Revenue (US$ Million) Market Share by Application (2022-2027)
Table 67. China Ranitidine (Zantac) Revenue Share by Application (2022-2027)
Table 68. China Ranitidine (Zantac) Price (US$/Unit) by Application (2022-2027)
Table 69. North America Ranitidine (Zantac) Sales by Country (2016-2021) & (K Units)
Table 70. North America Ranitidine (Zantac) Sales Market Share by Country (2016-2021)
Table 71. North America Ranitidine (Zantac) Revenue by Country (2016-2021) & (US$ Million)
Table 72. North America Ranitidine (Zantac) Revenue Market Share by Country (2016-2021)
Table 73. Asia Pacific Ranitidine (Zantac) Sales by Region (2016-2021) & (K Units)
Table 74. Asia Pacific Ranitidine (Zantac) Sales Market Share by Region (2016-2021)
Table 75. Asia Pacific Ranitidine (Zantac) Revenue by Region (2016-2021) & (US$ Million)
Table 76. Asia Pacific Ranitidine (Zantac) Revenue Market Share by Region (2016-2021)
Table 77. Europe Ranitidine (Zantac) Sales by Country (2016-2021) & (K Units)
Table 78. Europe Ranitidine (Zantac) Sales Market Share by Country (2016-2021)
Table 79. Europe Ranitidine (Zantac) Revenue by Country (2016-2021) & (US$ Million)
Table 80. Europe Ranitidine (Zantac) Revenue Market Share by Country (2016-2021)
Table 81. Latin America Ranitidine (Zantac) Sales by Country (2016-2021) & (K Units)
Table 82. Latin America Ranitidine (Zantac) Sales Market Share by Country (2016-2021)
Table 83. Latin Americaa Ranitidine (Zantac) Revenue by Country (2016-2021) & (US$ Million)
Table 84. Latin America Ranitidine (Zantac) Revenue Market Share by Country (2016-2021)
Table 85. Middle East and Africa Ranitidine (Zantac) Sales by Country (2016-2021) & (K Units)
Table 86. Middle East and Africa Ranitidine (Zantac) Sales Market Share by Country (2016-2021)
Table 87. Middle East and Africa Ranitidine (Zantac) Revenue by Country (2016-2021) & (US$ Million)
Table 88. Middle East and Africa Ranitidine (Zantac) Revenue Market Share by Country (2016-2021)
Table 89. Sanofi-Aventis Corporation Information
Table 90. Sanofi-Aventis Description and Business Overview
Table 91. Sanofi-Aventis Ranitidine (Zantac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 92. Sanofi-Aventis Ranitidine (Zantac) Product
Table 93. Sanofi-Aventis Recent Development
Table 94. GlaxoSmithKline Corporation Information
Table 95. GlaxoSmithKline Description and Business Overview
Table 96. GlaxoSmithKline Ranitidine (Zantac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 97. GlaxoSmithKline Product
Table 98. GlaxoSmithKline Recent Development
Table 99. Hi-Tech Pharmacal Co. Corporation Information
Table 100. Hi-Tech Pharmacal Co. Description and Business Overview
Table 101. Hi-Tech Pharmacal Co. Ranitidine (Zantac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 102. Hi-Tech Pharmacal Co. Product
Table 103. Hi-Tech Pharmacal Co. Recent Development
Table 104. Sun Pharma Corporation Information
Table 105. Sun Pharma Description and Business Overview
Table 106. Sun Pharma Ranitidine (Zantac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 107. Sun Pharma Product
Table 108. Sun Pharma Recent Development
Table 109. Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Corporation Information
Table 110. Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Description and Business Overview
Table 111. Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Ranitidine (Zantac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 112. Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Product
Table 113. Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Recent Development
Table 114. Dr. Reddy’s Laboratories Inc. Corporation Information
Table 115. Dr. Reddy’s Laboratories Inc. Description and Business Overview
Table 116. Dr. Reddy’s Laboratories Inc. Ranitidine (Zantac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 117. Dr. Reddy’s Laboratories Inc. Product
Table 118. Dr. Reddy’s Laboratories Inc. Recent Development
Table 119. Sandoz Inc. (part of Novartis AG) Corporation Information
Table 120. Sandoz Inc. (part of Novartis AG) Description and Business Overview
Table 121. Sandoz Inc. (part of Novartis AG) Ranitidine (Zantac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 122. Sandoz Inc. (part of Novartis AG) Product
Table 123. Sandoz Inc. (part of Novartis AG) Recent Development
Table 124. Strides (and Strides Arcolab international) Corporation Information
Table 125. Strides (and Strides Arcolab international) Description and Business Overview
Table 126. Strides (and Strides Arcolab international) Ranitidine (Zantac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 127. Strides (and Strides Arcolab international) Product
Table 128. Strides (and Strides Arcolab international) Recent Development
Table 129. Geri-Care Pharmaceuticals Corporation Information
Table 130. Geri-Care Pharmaceuticals Description and Business Overview
Table 131. Geri-Care Pharmaceuticals Ranitidine (Zantac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 132. Geri-Care Pharmaceuticals Product
Table 133. Geri-Care Pharmaceuticals Recent Development
Table 134. PAI Holdings, LLC Corporation Information
Table 135. PAI Holdings, LLC Description and Business Overview
Table 136. PAI Holdings, LLC Ranitidine (Zantac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 137. PAI Holdings, LLC Product
Table 138. PAI Holdings, LLC Recent Development
Table 139. Teva Pharmaceuticals Corporation Information
Table 140. Teva Pharmaceuticals Description and Business Overview
Table 141. Teva Pharmaceuticals Ranitidine (Zantac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 142. Teva Pharmaceuticals Product
Table 143. Teva Pharmaceuticals Recent Development
Table 144. Granules Pharmaceuticals Inc. Corporation Information
Table 145. Granules Pharmaceuticals Inc. Description and Business Overview
Table 146. Granules Pharmaceuticals Inc. Ranitidine (Zantac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 147. Granules Pharmaceuticals Inc. Product
Table 148. Granules Pharmaceuticals Inc. Recent Development
Table 149. Glenmark Pharmaceuticals (and Glenmark Generics) Corporation Information
Table 150. Glenmark Pharmaceuticals (and Glenmark Generics) Description and Business Overview
Table 151. Glenmark Pharmaceuticals (and Glenmark Generics) Ranitidine (Zantac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 152. Glenmark Pharmaceuticals (and Glenmark Generics) Product
Table 153. Glenmark Pharmaceuticals (and Glenmark Generics) Recent Development
Table 154. Apotex Inc. (and Apotex Corporation) Corporation Information
Table 155. Apotex Inc. (and Apotex Corporation) Description and Business Overview
Table 156. Apotex Inc. (and Apotex Corporation) Ranitidine (Zantac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 157. Apotex Inc. (and Apotex Corporation) Product
Table 158. Apotex Inc. (and Apotex Corporation) Recent Development
Table 159. Hikma Pharmaceuticals (West-ward Pharmaceuticals) Corporation Information
Table 160. Hikma Pharmaceuticals (West-ward Pharmaceuticals) Description and Business Overview
Table 161. Hikma Pharmaceuticals (West-ward Pharmaceuticals) Ranitidine (Zantac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 162. Hikma Pharmaceuticals (West-ward Pharmaceuticals) Product
Table 163. Hikma Pharmaceuticals (West-ward Pharmaceuticals) Recent Development
Table 164. Ranitidine (Zantac) Market Trends
Table 165. Ranitidine (Zantac) Market Drivers
Table 166. Ranitidine (Zantac) Market Challenges
Table 167. Ranitidine (Zantac) Market Restraints
Table 168. Ranitidine (Zantac) Customers List
Table 169. Ranitidine (Zantac) Distributors List
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Ranitidine (Zantac) Product Picture
Figure 2. Global Ranitidine (Zantac) Sales Market Share by Type in 2020 & 2027
Figure 3. Ranitidine Capsule Product Picture
Figure 4. Ranitidine Oral Tablet Product Picture
Figure 5. Ranitidine Injectable Solution Product Picture
Figure 6. Ranitidine Oral Syrup Product Picture
Figure 7. Global Ranitidine (Zantac) Sales Market Share by Application in 2020 & 2027
Figure 8. Hospital Pharmacy
Figure 9. Retail Pharmacy
Figure 10. Online Pharmacy
Figure 11. Ranitidine (Zantac) Report Years Considered
Figure 12. Global Ranitidine (Zantac) Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Ranitidine (Zantac) Market Size 2016-2027 (US$ Million)
Figure 14. Global Ranitidine (Zantac) Sales 2016-2027 (K Units)
Figure 15. Global Ranitidine (Zantac) Market Size Market Share by Region: 2021 Versus 2027
Figure 16. Global Ranitidine (Zantac) Sales Market Share by Region (2016-2021)
Figure 17. Global Ranitidine (Zantac) Sales Market Share by Region in 2020
Figure 18. Global Ranitidine (Zantac) Revenue Market Share by Region (2016-2021)
Figure 19. Global Ranitidine (Zantac) Revenue Market Share by Region in 2020
Figure 20. Global Ranitidine (Zantac) Sales Share by Manufacturer in 2020
Figure 21. The Top 10 and 5 Players Market Share by Ranitidine (Zantac) Revenue in 2020
Figure 22. Ranitidine (Zantac) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 23. Global Ranitidine (Zantac) Sales Market Share by Type (2016-2021)
Figure 24. Global Ranitidine (Zantac) Sales Market Share by Type in 2020
Figure 25. Global Ranitidine (Zantac) Revenue Market Share by Type (2016-2021)
Figure 26. Global Ranitidine (Zantac) Revenue Market Share by Type in 2020
Figure 27. Global Ranitidine (Zantac) Sales Market Share by Application (2016-2021)
Figure 28. Global Ranitidine (Zantac) Sales Market Share by Application in 2020
Figure 29. Global Ranitidine (Zantac) Revenue Market Share by Application (2016-2021)
Figure 30. Global Ranitidine (Zantac) Revenue Market Share by Application in 2020
Figure 31. China Ranitidine (Zantac) Sales Growth Rate 2016-2027 (K Units)
Figure 32. China Ranitidine (Zantac) Revenue Growth Rate 2016-2027 (US$ Million)
Figure 33. China Ranitidine (Zantac) Market Share in Global Market 2016-2027
Figure 34. China 5 and 10 Largest Ranitidine (Zantac) Players Market Share by Revenue in Ranitidine (Zantac) in 2020
Figure 35. China Ranitidine (Zantac) Revenue Share by Type (2016-2021)
Figure 36. China Ranitidine (Zantac) Revenue Growth Rate by Type in 2016 & 2020
Figure 37. China Ranitidine (Zantac) Revenue Share by Application (2016-2021)
Figure 38. China Ranitidine (Zantac) Revenue Growth Rate by Application in 2016 & 2020
Figure 39. North America Ranitidine (Zantac) Sales Growth Rate 2016-2021 (K Units)
Figure 40. North America Ranitidine (Zantac) Revenue Growth Rate 2016-2021 (US$ Million)
Figure 41. North America Ranitidine (Zantac) Sales Market Share by Country in 2020
Figure 42. North America Ranitidine (Zantac) Revenue Market Share by Country in 2020
Figure 43. U.S. Ranitidine (Zantac) Sales Growth Rate (2016-2021) (K Units)
Figure 44. U.S. Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Canada Ranitidine (Zantac) Sales Growth Rate (2016-2021) (K Units)
Figure 46. Canada Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Europe Ranitidine (Zantac) Sales Growth Rate 2016-2021 (K Units)
Figure 48. Europe Ranitidine (Zantac) Revenue Growth Rate 2016-2021 (US$ Million)
Figure 49. Europe Ranitidine (Zantac) Sales Market Share by Country in 2020
Figure 50. Europe Ranitidine (Zantac) Revenue Market Share by Country in 2020
Figure 51. Germany Ranitidine (Zantac) Sales Growth Rate (2016-2021) (K Units)
Figure 52. Germany Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. France Ranitidine (Zantac) Sales Growth Rate (2016-2021) (K Units)
Figure 54. France Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. U.K. Ranitidine (Zantac) Sales Growth Rate (2016-2021) (K Units)
Figure 56. U.K. Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Italy Ranitidine (Zantac) Sales Growth Rate (2016-2021) (K Units)
Figure 58. Italy Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Russia Ranitidine (Zantac) Sales Growth Rate (2016-2021) (K Units)
Figure 60. Russia Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Asia Pacific Ranitidine (Zantac) Sales Growth Rate 2016-2021 (K Units)
Figure 62. Asia Pacific Ranitidine (Zantac) Revenue Growth Rate 2016-2021 (US$ Million)
Figure 63. Asia Pacific Ranitidine (Zantac) Sales Market Share by Region in 2020
Figure 64. Asia Pacific Ranitidine (Zantac) Revenue Market Share by Region in 2020
Figure 65. China Ranitidine (Zantac) Sales Growth Rate (2016-2021) (K Units)
Figure 66. China Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. Japan Ranitidine (Zantac) Sales Growth Rate (2016-2021) (K Units)
Figure 68. Japan Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. South Korea Ranitidine (Zantac) Sales Growth Rate (2016-2021) (K Units)
Figure 70. South Korea Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. India Ranitidine (Zantac) Sales Growth Rate (2016-2021) (K Units)
Figure 72. India Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Australia Ranitidine (Zantac) Sales Growth Rate (2016-2021) (K Units)
Figure 74. Australia Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Taiwan Ranitidine (Zantac) Sales Growth Rate (2016-2021) (K Units)
Figure 76. Taiwan Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Indonesia Ranitidine (Zantac) Sales Growth Rate (2016-2021) (K Units)
Figure 78. Indonesia Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Thailand Ranitidine (Zantac) Sales Growth Rate (2016-2021) (K Units)
Figure 80. Thailand Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Malaysia Ranitidine (Zantac) Sales Growth Rate (2016-2021) (K Units)
Figure 82. Malaysia Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Philippines Ranitidine (Zantac) Sales Growth Rate (2016-2021) (K Units)
Figure 84. Philippines Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Vietnam Ranitidine (Zantac) Sales Growth Rate (2016-2021) (K Units)
Figure 86. Vietnam Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 87. Latin America Ranitidine (Zantac) Sales Growth Rate 2016-2021 (K Units)
Figure 88. Latin America Ranitidine (Zantac) Revenue Growth Rate 2016-2021 (US$ Million)
Figure 89. Latin America Ranitidine (Zantac) Sales Market Share by Country in 2020
Figure 90. Latin America Ranitidine (Zantac) Revenue Market Share by Country in 2020
Figure 91. Mexico Ranitidine (Zantac) Sales Growth Rate (2016-2021) (K Units)
Figure 92. Mexico Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 93. Brazil Ranitidine (Zantac) Sales Growth Rate (2016-2021) (K Units)
Figure 94. Brazil Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 95. Argentina Ranitidine (Zantac) Sales Growth Rate (2016-2021) (K Units)
Figure 96. Argentina Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 97. Middle East and Africa Ranitidine (Zantac) Sales Growth Rate 2016-2021 (K Units)
Figure 98. Middle East and Africa Ranitidine (Zantac) Revenue Growth Rate 2016-2021 (US$ Million)
Figure 99. Middle East and Africa Ranitidine (Zantac) Sales Market Share by Country in 2020
Figure 100. Middle East and Africa Ranitidine (Zantac) Revenue Market Share by Country in 2020
Figure 101. Turkey Ranitidine (Zantac) Sales Growth Rate (2016-2021) (K Units)
Figure 102. Turkey Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 103. Saudi Arabia Ranitidine (Zantac) Sales Growth Rate (2016-2021) (K Units)
Figure 104. Saudi Arabia Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 105. UAE Ranitidine (Zantac) Sales Growth Rate (2016-2021) (K Units)
Figure 106. UAE Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 107. Ranitidine (Zantac) Value Chain
Figure 108. Channels of Distribution
Figure 109. Distributors Profiles
Figure 110. Bottom-up and Top-down Approaches for This Report
Figure 111. Data Triangulation
Figure 112. Key Executives Interviewed
ラニチジン（ザンタック）の世界市場 2020年 Market Overview The Ranitidine (Zantac) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…- 病院及び薬局用ロボットの世界市場 2020年 Market Overview The global Hospital and Pharmacy Robotics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hospital and P…
- 薬局自動化システムの世界及び中国市場 Pharmacy Automation is the mechanization or automation of tasks and processes performed in pharmacy or other health care settings. It includes process like medication dispensing, packaging, labeling, storage and retrieval systems and table top counters. The pharmacy automation not only streamline ph…
- 薬局小売の世界市場 2020年 Market Overview The Pharmacy Retailing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
- 薬局管理システムの世界市場 2020年 Market Overview The global Pharmacy Management System market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 7.0% in the forecast period of 2020 to 2025 and will expected to reach USD 561040 million by 2025, from USD 428390 million in 2019. The Pharmacy …